Vaccine targets vancomycin-resistant bacteria.
In: World Disease Weekly Plus, 1998-05-11, S. 7-8
serialPeriodical
Zugriff:
Announces the presentation of the studies on antibodies to a new vaccine antigen protected mice against vancomycin-resistant bacterium by Nabi, a biotechnology firm, in Boca Raton, Florida at the `98th General Meeting of the American Society for Microbiology,' on May 17-21, 1998, in Atlanta, Georgia. Species responsible for the development of diseases in normal human intestinal flora; Immunotherapeutic products approved by the Nabi.
Titel: |
Vaccine targets vancomycin-resistant bacteria.
|
---|---|
Autor/in / Beteiligte Person: | DeNoon, Daniel J. |
Zeitschrift: | World Disease Weekly Plus, 1998-05-11, S. 7-8 |
Veröffentlichung: | 1998 |
Medientyp: | serialPeriodical |
ISSN: | 1078-2850 (print) |
Sonstiges: |
|